Search for: "ASTRAZENECA UK LIMITED"
Results 21 - 40
of 73
Sorted by Relevance
|
Sort by Date
3 Apr 2017, 10:55 pm
(T-321/05 AstraZeneca v Commission [2010] ECR II-2805). [read post]
19 Oct 2021, 1:52 pm
Short shrift was given to the Marhedge decision and Eyre J agreed with the judge in the subsequent decision of AstraZeneca UK Ltd v. [read post]
17 Nov 2010, 1:48 am
(Patent Baristas) A round up of international events – Access and Benefit Sharing Protocol; review of Para 6 system; concerns with ACTA’s compatibility with TRIPS(Spicy IP) Compromise UN protocol treaty against biopiracy adopted in Japan (IP Watch) (Innovation Law Blog) TRIPS Council discusses efficacy of ACTA, public health amendment (IP Watch) Altering genes in crops (IP Osgoode) Asia Pacific Pharmas moving away from generics (GenericsWeb) Belgium Commercial Court: No faultless… [read post]
4 Sep 2014, 1:00 am
So changing the CGK analysis inevitably changes the test for inventive step.All of this helps explain why the IPKat is so exercised by yesterday’s decision in Teva UK Limited & another v AstraZeneca AB [2014] EWHC 2873 (Pat), decided by Mr Justice Sales in the Patents Court. [read post]
25 Jan 2017, 10:48 pm
Andrew considered that the days of proffering a raft of last minute amendments are over both in the UK and at the EPO. [read post]
27 Feb 2009, 5:00 am
USA, Inc (Orange Book Blog) (FDA Law Blog) (Patent Baristas) (Law360) (Patent Docs) (Patent Prospector) (Patently-O) (GenericsWeb) (Hal Wegner) Cipramil (Citalopram) – UK: House of Lords upholds second-generation patent that had been invalidated at first instance for insufficiency: Generics (UK) Limited and others v H Lundbeck A/S (Managing Intellectual Property)(IPKat) US: Congressman Waxman tells GPhA meeting that Hatch-Waxman model will work for follow-on… [read post]
5 Jul 2020, 5:43 am
"The IP Federation has been a leader in shaping laws impacting IP-rich industry in the UK and Europe. [read post]
23 Nov 2007, 9:00 am
: (SpicyIP), Moving towards the nano age: (SpicyIP), YouTube (Google) and T-Series copyright dispute: (SpicyIP), (TechWhack), JapanIP Value in Japan - the alternative view: (IAM),South KoreaSouth Korea has been urged to strengthen its intellectual property rules in order to sign a free trade agreement with the European Union: (Intellectual Property Watch)The NetherlandsDutch teenager arrested, and another five questioned by police, for allegedly stealing virtual furniture from… [read post]
14 Jul 2010, 6:47 pm
Stallergenes (EPLAW) UK: Discovery of documents: is there a real benefit? [read post]
8 Dec 2010, 2:20 am
Allergan, Inc (Docket Report) Products Enbrel (Etanercept) – Israel: Patent status in question, in need of legislative fix (America-Israel Patent Law) Fabrazyme (Alpha-galactosidase) – US: Statements by KEI and others on NIH rejection of Fabrazyme march-in request (KEI) Intuniv (Guanfacine) – US: Impax confirms patent challenge relating to Intuniv (GenericsWeb) Lovenox (Enoxaparin) – US: Momenta sues Teva over claims relating to ways of manufacturing and analysing structure… [read post]
12 Mar 2020, 1:48 am
In relation to AstraZeneca, Chris considered that the objection was basically that the company was insufficiently transparent – but he said it was hard to see how it could actually be considered anticompetitive. [read post]
8 Jun 2015, 4:20 am
This question, posed in relation to the law of the Bahamas, was answered by the Privy Council in Gold Rock Limited v Nylund Hylton [2015] UKPC 17, about which guest blogger Kevin Winters tells all.Copyright cases for the CJEU: have your sayTwo more references, respectively from Germany and the Netherlands, are heading the CJEU’s desks. [read post]
25 Mar 2021, 1:24 pm
For J&J and AstraZeneca, the science is similarly straightforward but takes about twice as long (3 months). [read post]
3 Aug 2011, 3:31 am
422/10 Georgetown University v Comptroller-General of Patents, Designs and Trade Marks (The SPC Blog) France: Limitation of the French designation of a European patent: before which office? [read post]
30 Jun 2021, 10:31 am
The Oxford-AstraZeneca and Novavax vaccines showed the same pattern. [read post]
8 Feb 2021, 9:16 am
It must be understood that if the invention is limited to the content of the patent, the scope of its protection, on the contrary, leaves room for interpretation by the Judge. [read post]
30 Jul 2015, 4:46 am
– Three (19%) impose geographic restrictions on which employees are included in the comparator group (e.g., limiting to strictly U.S. or UK employees). [read post]
8 Sep 2014, 4:55 am
.* The skilled person - more knowledgeable than ever beforeDavid covers the exciting pharma-patent ruling in Teva UK Limited & another v AstraZeneca AB [2014] EWHC 2873 (Pat) by Mr Justice Sales in the Patents Court for England and Wales, which focuses on the concept of Common General Knowledge (CGK). [read post]
13 Mar 2009, 2:00 am
(GenericsWeb) India’s Human Genome Bill (Spicy IP) Indian drugmakers push into US generics market (GenericsWeb) Uganda: Indian generic manufacturers concerned anti-counterfeit legislation may threaten market in Uganda and surrounding territories (Afro-IP) UK: Court of Appeal admonishes counsel for dilatory actions involved in parallel British and EPO proceedings: Eli Lilly & Co v Human Genome Sciences (Hal Wegner) (PatLit) US: President Obama to lift stem cell… [read post]
9 Nov 2008, 11:48 pm
Boston Globe AHN Pharmalot Over the Limit Market Watch About CTV Canada The Heart.org Medpage Today Cardiosource RTT News Metro UK Short News.com Current World News EurekAlert Canada News Wire The Wall Street Journal 0Digg me [read post]
